Arizona joins the ever-growing list of American states harboring a variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
New coronavirus variant with E484K mutation detected in Arizona
Home ยป
Why does convalescent plasma therapy for severe COVID-19 show mixed success?
Treatment modalities against the coronavirus disease 2019 (COVID-19) pandemic are limited in efficacy. This has led many centers to use
Why does convalescent plasma therapy for severe COVID-19 show mixed success?
Treatment modalities against the coronavirus disease 2019 (COVID-19) pandemic are limited in efficacy. This has led many centers to use
What is a protective neutralizing antibody titer against SARS-CoV-2 infection?
Caused by the worldwide spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus disease 2019 (COVID-19) pandemic continues
What is a protective neutralizing antibody titer against SARS-CoV-2 infection?
Caused by the worldwide spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus disease 2019 (COVID-19) pandemic continues
Study reports lasting immune response in convalescent COVID-19 patients
Using different types of assays, researchers found both cellular and humoral immune responses for up to eight months in coronavirus
Metal-chemotherapy can immune enhance therapies for cancer
Metal-containing chemotherapies, strengthen the immune response against cancer So far, with a metal-containing chemotherapies have been brought more damage to